Spots Global Cancer Trial Database for standard radiation therapy
Every month we try and update this database with for standard radiation therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Trial of Hypofractionated Radiation Therapy for Glioblastoma | NCT02206230 | Glioblastoma | Hypofractionate... Standard radiat... | 18 Years - 70 Years | AHS Cancer Control Alberta | |
Molecular Profiling for Individualized Treatment Plan for DIPG | NCT02274987 | Diffuse Intrins... | Specialized tum... Standard radiat... | - 25 Years | University of California, San Francisco | |
MRSI to Predict Response to RT/TMZ ± Belinostat in GBM | NCT02137759 | Glioblastoma Mu... | Standard Radiat... Standard Temozo... Belinostat | 18 Years - | Emory University | |
Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme | NCT00209989 | Glioblastoma Mu... | Zarnestra standard Radiat... | 18 Years - | Institut Claudius Regaud | |
A Randomized Trial Evaluating Rapid Delivery of Dose Escalated Hypofractionated Radiotherapy for Patients Diagnosed With Bone Metastases for Effective Palliation of Symptoms | NCT02163226 | Bone Metastases | Hypofractionate... One Radiation T... Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell Carcinoma of the Head and Neck | NCT00427102 | Squamous Cell C... Head and Neck C... Resected Head a... Mucositis | Oral MRX-1024 Standard Fracti... High-Dose Cispl... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Trial of Hypofractionated Radiation Therapy for Glioblastoma | NCT02206230 | Glioblastoma | Hypofractionate... Standard radiat... | 18 Years - 70 Years | AHS Cancer Control Alberta | |
Trial of Hypofractionated Radiation Therapy for Glioblastoma | NCT02206230 | Glioblastoma | Hypofractionate... Standard radiat... | 18 Years - 70 Years | AHS Cancer Control Alberta | |
Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme | NCT00209989 | Glioblastoma Mu... | Zarnestra standard Radiat... | 18 Years - | Institut Claudius Regaud | |
A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic Cancer | NCT01986738 | Pancreatic Canc... | Standard Radiat... Active Breathin... Computed Tomogr... | 18 Years - | University of Michigan Rogel Cancer Center | |
A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic Cancer | NCT01986738 | Pancreatic Canc... | Standard Radiat... Active Breathin... Computed Tomogr... | 18 Years - | University of Michigan Rogel Cancer Center | |
MRSI to Predict Response to RT/TMZ ± Belinostat in GBM | NCT02137759 | Glioblastoma Mu... | Standard Radiat... Standard Temozo... Belinostat | 18 Years - | Emory University | |
A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic Cancer | NCT01986738 | Pancreatic Canc... | Standard Radiat... Active Breathin... Computed Tomogr... | 18 Years - | University of Michigan Rogel Cancer Center |